Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'AtheroGenics, Inc. - Strategic Analysis Review' returned 4 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Astellas Pharma: Performance, Products, Pipeline and Potential   Espicom Business Intelligence Ltd, Jan 2010, Pages: 146 and detail - A full 5-year financial performance assessment - Key corporate events - Key agreements - Infrastructure - Subsidiaries and joint ventures Ajinomoto Co Inc American BioScience Inc (ABS) AtheroGenics AtheroGenics, Inc.   Wright Investors' Service, May 2012, Pages: 41 AtheroGenics, Inc. Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency Angina Global Clinical Trials Review, Q4, 2010   GlobalData, Dec 2010, Pages: 64 Foundation, Inc. Medicure Inc. Clinical Trial Overview of Medicure Inc. AtheroGenics, Inc. Clinical Trial Overview of AtheroGenics, Inc. Novartis AG Clinical Trial Overview of Novartis AG Ablynx NV Dyslipidemia: Opportunities in Cardiovascular Risk Reduction   Biophoenix Limited, July 2008, Pages: 210 . Ark Therapeutics 12. Astellas 13. AstraZeneca 14. AtheroGenics 15. Avanir 16. Bayer 17. Bebaas 18. BioInvent 19. BioLineRx 20. Biovitrum 21. Bristol-Myers Squibb 22. Celera Genomics 23. Cerenis 24 Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets2    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network